Selected research
Industry Research
Medical Polyglycolic Acid (PGA) Industry Research Report 2026
Market perspective
The global Medical Polyglycolic Acid (PGA) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Medical Polyglycolic Acid (PGA) is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Medical Polyglycolic Acid (PGA) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Medical Polyglycolic Acid (PGA) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Medical Polyglycolic Acid (PGA) include among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Medical Polyglycolic Acid (PGA) market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Medical Polyglycolic Acid (PGA).
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Medical Polyglycolic Acid (PGA) Market by Company
Sinopec
Yulin Energy Group
Evonik
Shanghai Pujing Chemical
Huayang Medical
Danhua Technology
Shenzhen Polymtek Biomaterial
Kureha
Medical Polyglycolic Acid (PGA) Segment by Type
Copolymer
Homopolymer
Block Copolymers
Medical Polyglycolic Acid (PGA) Segment by Application
Tissue Engineering Scaffold
Medical Suture
Drug Controlled Release Carrier
Fracture Fixation Material
Stitched Reinforcement Material
Medical Polyglycolic Acid (PGA) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Polyglycolic Acid (PGA) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Polyglycolic Acid (PGA) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Polyglycolic Acid (PGA).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Medical Polyglycolic Acid (PGA) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Medical Polyglycolic Acid (PGA) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Medical Polyglycolic Acid (PGA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Copolymer
- Homopolymer
- Block Copolymers
Applications
- Tissue Engineering Scaffold
- Medical Suture
- Drug Controlled Release Carrier
- Fracture Fixation Material
- Stitched Reinforcement Material
Companies covered
- Sinopec
- Yulin Energy Group
- Evonik
- Shanghai Pujing Chemical
- Huayang Medical
- Danhua Technology
- Shenzhen Polymtek Biomaterial
- Kureha
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Medical Polyglycolic Acid (PGA) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Copolymer
- 2.2.3 Homopolymer
- 2.2.4 Block Copolymers
- 2.3 Medical Polyglycolic Acid (PGA) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tissue Engineering Scaffold
- 2.3.3 Medical Suture
- 2.3.4 Drug Controlled Release Carrier
- 2.3.5 Fracture Fixation Material
- 2.3.6 Stitched Reinforcement Material
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Medical Polyglycolic Acid (PGA) Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Medical Polyglycolic Acid (PGA) Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Medical Polyglycolic Acid (PGA) Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Medical Polyglycolic Acid (PGA) Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Medical Polyglycolic Acid (PGA) Production by Manufacturers (2021-2026)
- 3.2 Global Medical Polyglycolic Acid (PGA) Production Value by Manufacturers (2021-2026)
- 3.3 Global Medical Polyglycolic Acid (PGA) Average Price by Manufacturers (2021-2026)
- 3.4 Global Medical Polyglycolic Acid (PGA) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medical Polyglycolic Acid (PGA) Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Medical Polyglycolic Acid (PGA) Manufacturers, Product Type & Application
- 3.7 Global Medical Polyglycolic Acid (PGA) Manufacturers Established Date
- 3.8 Global Medical Polyglycolic Acid (PGA) Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sinopec
- 4.1.1 Sinopec Medical Polyglycolic Acid (PGA) Company Information
- 4.1.2 Sinopec Medical Polyglycolic Acid (PGA) Business Overview
- 4.1.3 Sinopec Medical Polyglycolic Acid (PGA) Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Sinopec Product Portfolio
- 4.1.5 Sinopec Recent Developments
- 4.2 Yulin Energy Group
- 4.2.1 Yulin Energy Group Medical Polyglycolic Acid (PGA) Company Information
- 4.2.2 Yulin Energy Group Medical Polyglycolic Acid (PGA) Business Overview
- 4.2.3 Yulin Energy Group Medical Polyglycolic Acid (PGA) Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Yulin Energy Group Product Portfolio
- 4.2.5 Yulin Energy Group Recent Developments
- 4.3 Evonik
- 4.3.1 Evonik Medical Polyglycolic Acid (PGA) Company Information
- 4.3.2 Evonik Medical Polyglycolic Acid (PGA) Business Overview
- 4.3.3 Evonik Medical Polyglycolic Acid (PGA) Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 Evonik Product Portfolio
- 4.3.5 Evonik Recent Developments
- 4.4 Shanghai Pujing Chemical
- 4.4.1 Shanghai Pujing Chemical Medical Polyglycolic Acid (PGA) Company Information
- 4.4.2 Shanghai Pujing Chemical Medical Polyglycolic Acid (PGA) Business Overview
- 4.4.3 Shanghai Pujing Chemical Medical Polyglycolic Acid (PGA) Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Shanghai Pujing Chemical Product Portfolio
- 4.4.5 Shanghai Pujing Chemical Recent Developments
- 4.5 Huayang Medical
- 4.5.1 Huayang Medical Medical Polyglycolic Acid (PGA) Company Information
- 4.5.2 Huayang Medical Medical Polyglycolic Acid (PGA) Business Overview
- 4.5.3 Huayang Medical Medical Polyglycolic Acid (PGA) Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Huayang Medical Product Portfolio
- 4.5.5 Huayang Medical Recent Developments
- 4.6 Danhua Technology
- 4.6.1 Danhua Technology Medical Polyglycolic Acid (PGA) Company Information
- 4.6.2 Danhua Technology Medical Polyglycolic Acid (PGA) Business Overview
- 4.6.3 Danhua Technology Medical Polyglycolic Acid (PGA) Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Danhua Technology Product Portfolio
- 4.6.5 Danhua Technology Recent Developments
- 4.7 Shenzhen Polymtek Biomaterial
- 4.7.1 Shenzhen Polymtek Biomaterial Medical Polyglycolic Acid (PGA) Company Information
- 4.7.2 Shenzhen Polymtek Biomaterial Medical Polyglycolic Acid (PGA) Business Overview
- 4.7.3 Shenzhen Polymtek Biomaterial Medical Polyglycolic Acid (PGA) Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 Shenzhen Polymtek Biomaterial Product Portfolio
- 4.7.5 Shenzhen Polymtek Biomaterial Recent Developments
- 4.8 Kureha
- 4.8.1 Kureha Medical Polyglycolic Acid (PGA) Company Information
- 4.8.2 Kureha Medical Polyglycolic Acid (PGA) Business Overview
- 4.8.3 Kureha Medical Polyglycolic Acid (PGA) Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Kureha Product Portfolio
- 4.8.5 Kureha Recent Developments
5 Global Medical Polyglycolic Acid (PGA) Production by Region
- 5.1 Global Medical Polyglycolic Acid (PGA) Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Medical Polyglycolic Acid (PGA) Production by Region: 2021-2032
- 5.2.1 Global Medical Polyglycolic Acid (PGA) Production by Region: 2021-2026
- 5.2.2 Global Medical Polyglycolic Acid (PGA) Production Forecast by Region (2027-2032)
- 5.3 Global Medical Polyglycolic Acid (PGA) Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Medical Polyglycolic Acid (PGA) Production Value by Region: 2021-2032
- 5.4.1 Global Medical Polyglycolic Acid (PGA) Production Value by Region: 2021-2026
- 5.4.2 Global Medical Polyglycolic Acid (PGA) Production Value Forecast by Region (2027-2032)
- 5.5 Global Medical Polyglycolic Acid (PGA) Market Price Analysis by Region (2021-2026)
- 5.6 Global Medical Polyglycolic Acid (PGA) Production and Value, YOY Growth
- 5.6.1 North America Medical Polyglycolic Acid (PGA) Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Medical Polyglycolic Acid (PGA) Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Medical Polyglycolic Acid (PGA) Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Medical Polyglycolic Acid (PGA) Production Value Estimates and Forecasts (2021-2032)
6 Global Medical Polyglycolic Acid (PGA) Consumption by Region
- 6.1 Global Medical Polyglycolic Acid (PGA) Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Medical Polyglycolic Acid (PGA) Consumption by Region (2021-2032)
- 6.2.1 Global Medical Polyglycolic Acid (PGA) Consumption by Region: 2021-2026
- 6.2.2 Global Medical Polyglycolic Acid (PGA) Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Medical Polyglycolic Acid (PGA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Medical Polyglycolic Acid (PGA) Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Medical Polyglycolic Acid (PGA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Medical Polyglycolic Acid (PGA) Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Medical Polyglycolic Acid (PGA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Medical Polyglycolic Acid (PGA) Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Medical Polyglycolic Acid (PGA) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Medical Polyglycolic Acid (PGA) Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Medical Polyglycolic Acid (PGA) Production by Type (2021-2032)
- 7.1.1 Global Medical Polyglycolic Acid (PGA) Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Medical Polyglycolic Acid (PGA) Production Market Share by Type (2021-2032)
- 7.2 Global Medical Polyglycolic Acid (PGA) Production Value by Type (2021-2032)
- 7.2.1 Global Medical Polyglycolic Acid (PGA) Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Medical Polyglycolic Acid (PGA) Production Value Market Share by Type (2021-2032)
- 7.3 Global Medical Polyglycolic Acid (PGA) Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Medical Polyglycolic Acid (PGA) Production by Application (2021-2032)
- 8.1.1 Global Medical Polyglycolic Acid (PGA) Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Medical Polyglycolic Acid (PGA) Production Market Share by Application (2021-2032)
- 8.2 Global Medical Polyglycolic Acid (PGA) Production Value by Application (2021-2032)
- 8.2.1 Global Medical Polyglycolic Acid (PGA) Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Medical Polyglycolic Acid (PGA) Production Value Market Share by Application (2021-2032)
- 8.3 Global Medical Polyglycolic Acid (PGA) Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Medical Polyglycolic Acid (PGA) Value Chain Analysis
- 9.1.1 Medical Polyglycolic Acid (PGA) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Medical Polyglycolic Acid (PGA) Production Mode & Process
- 9.2 Medical Polyglycolic Acid (PGA) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Medical Polyglycolic Acid (PGA) Distributors
- 9.2.3 Medical Polyglycolic Acid (PGA) Customers
10 Global Medical Polyglycolic Acid (PGA) Analyzing Market Dynamics
- 10.1 Medical Polyglycolic Acid (PGA) Industry Trends
- 10.2 Medical Polyglycolic Acid (PGA) Industry Drivers
- 10.3 Medical Polyglycolic Acid (PGA) Industry Opportunities and Challenges
- 10.4 Medical Polyglycolic Acid (PGA) Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst